You can’t manage what you don’t measure. That’s not a motivational poster — it’s the fundamental principle behind every successful enhancement protocol. Yet most guys in the biohacking and performance space are flying completely blind. They’re taking peptides, SARMs, supplements, and hormones without any idea what’s actually happening inside their bodies. That’s not enhancement — that’s gambling.
The Enhanced Man gets bloodwork. Not once a year at his annual physical where the doctor checks a basic metabolic panel and says “everything looks fine.” I’m talking about comprehensive, targeted bloodwork panels designed specifically for people who are actively optimizing their biochemistry. Here’s your complete guide to the biomarkers that actually matter.
The Essential Panel: Every Enhanced Man, Every 3-4 Months
Hormones
Total Testosterone — The headline number, but far from the whole story. Optimal range for the Enhanced Man: 700-1100 ng/dL. “Normal” lab ranges (264-916 ng/dL) include values from obese, sedentary, sleep-deprived men. Don’t accept “normal” — aim for optimal.
Free Testosterone — This is the testosterone actually available to your tissues. Total T can be high while free T is low if SHBG is elevated. Optimal: 15-25 pg/mL (direct measurement) or 2-3% of total T. This is arguably more important than total T.
Estradiol (E2) — Sensitive Assay — Must be the sensitive/LC-MS assay, not the standard immunoassay (which is designed for female ranges and wildly inaccurate for men). Optimal: 20-35 pg/mL. See the estrogen management protocol for details.
SHBG (Sex Hormone Binding Globulin) — The protein that binds testosterone and estradiol, making them unavailable. Optimal: 25-50 nmol/L. Too high = low free hormones. Too low = rapid hormone clearance and potentially excess free estrogen.
LH and FSH — Pituitary hormones that drive testicular function. Essential for diagnosing primary vs. secondary hypogonadism and monitoring any protocol that affects the HPG axis.
Prolactin — The silent performance killer. Fasting morning draw. Optimal: 5-12 ng/mL. Above 15 warrants investigation. See the prolactin control protocol.
DHEA-S — The reservoir hormone. Declines with age and is a marker of adrenal function and overall hormonal health. Optimal: 300-500 µg/dL for men under 50.
Thyroid Panel (TSH, Free T3, Free T4) — Thyroid function directly impacts metabolism, energy, cognition, and body composition. TSH alone is insufficient — you need free T3 and T4. Optimal TSH: 1.0-2.0 mIU/L (not just “within range”). Free T3: upper third of reference range. See the thyroid optimization protocol.
Metabolic Markers
Fasting Glucose — Target: 72-85 mg/dL. Above 90 fasting indicates insulin resistance is developing. Above 100 is pre-diabetic by definition.
Fasting Insulin — This catches insulin resistance 5-10 years before glucose starts rising. Target: 3-6 µIU/mL. Above 8 warrants aggressive metabolic intervention. See the insulin sensitivity stack.
HbA1c — Your 90-day average blood sugar. Target: 4.8-5.2%. The “normal” cutoff of 5.7% is already pre-diabetic territory. Don’t wait for the diagnosis — optimize now.
HOMA-IR — Calculated from fasting glucose and insulin. Target: under 1.0. This is the gold standard for assessing insulin sensitivity at a basic level. Formula: (Glucose mg/dL × Insulin µIU/mL) ÷ 405.
Lipids (Advanced Panel)
Total Cholesterol — Context-dependent. Meaningless without the breakdown below.
LDL-C and LDL-P (Particle Count) — LDL-C (concentration) doesn’t tell you how many LDL particles you have. LDL-P (particle number) is the true risk driver. You can have low LDL-C with high LDL-P (concordance mismatch) — this is a hidden risk factor. Target LDL-P: under 1000 nmol/L.
HDL-C — Higher is generally better. Target: above 50 mg/dL. HDL is anti-inflammatory, anti-oxidative, and helps clear arterial plaque.
Triglycerides — Target: under 80 mg/dL fasting. The triglyceride:HDL ratio is one of the best simple markers of insulin resistance. Target ratio: under 1.5.
Lp(a) — Genetically determined lipoprotein particle that dramatically increases cardiovascular risk when elevated. Test once — if elevated (above 50 mg/dL or 125 nmol/L), you need aggressive cardiovascular risk mitigation regardless of other lipid numbers. This cannot be significantly modified by lifestyle — it’s genetic.
ApoB — Total number of atherogenic particles. Increasingly considered the single best predictor of cardiovascular risk. Target: under 80 mg/dL for optimal, under 60 mg/dL for aggressive longevity optimization.
Inflammation Markers
hs-CRP (High-Sensitivity C-Reactive Protein) — Your primary systemic inflammation marker. Target: under 1.0 mg/L. Above 3.0 indicates significant inflammation that needs investigation. Chronic training without adequate recovery often keeps hs-CRP elevated.
Homocysteine — Cardiovascular risk marker and indicator of methylation status. Target: under 8 µmol/L. Elevated homocysteine responds well to TMG, B12, folate, and B6 supplementation.
Ferritin — Iron storage protein AND acute phase reactant. Elevated ferritin can indicate inflammation OR iron overload — context matters. Target: 40-150 ng/mL for men. Very high ferritin (>300) warrants iron studies and investigation.
Organ Function
Liver Panel (ALT, AST, GGT, Albumin, Bilirubin) — Essential for anyone using oral supplements or compounds that undergo hepatic metabolism. ALT and AST should be under 30 U/L for true optimal function. GGT is sensitive to alcohol, fatty liver, and bile duct issues. Support with TUDCA and NAC.
Kidney Panel (BUN, Creatinine, eGFR, Cystatin C) — Creatinine is affected by muscle mass, making eGFR unreliable in muscular individuals. Cystatin C provides a muscle-mass-independent assessment of kidney function and is essential for the Enhanced Man. Target eGFR: above 90 mL/min.
CBC (Complete Blood Count) — Monitors red blood cells (hematocrit/hemoglobin), white blood cells, and platelets. Testosterone optimization can increase hematocrit — watch for polycythemia (hematocrit above 52%). Elevated hematocrit increases blood viscosity and stroke risk.
The Advanced Panel: Twice Per Year
IGF-1 — Growth hormone’s downstream marker. Reflects GH secretion over time. Useful for monitoring MK-677, CJC-1295/Ipamorelin, or any GH-related protocol. Target: 200-300 ng/mL for optimal recovery and anabolism. Above 350 may increase certain cancer risks long-term.
Vitamin D (25-OH) — Most people are deficient despite supplementation. Target: 60-80 ng/mL. The “sufficient” cutoff of 30 ng/mL is woefully inadequate for optimization. See the D3+K2 protocol.
Omega-3 Index — Measures the percentage of EPA+DHA in your red blood cell membranes. Target: 8-12%. Below 4% = high cardiovascular risk. Most Americans are 3-4%. See the high-dose omega-3 protocol.
RBC Magnesium — Serum magnesium is useless — it’s tightly regulated and only drops when you’re severely depleted. RBC magnesium reflects intracellular stores. Most active people are magnesium-deficient.
Timing and Preparation
Fasting: 12-14 hours before draw for accurate glucose, insulin, lipids, and triglycerides.
Time of day: Morning (7-10am) for hormones. Testosterone peaks in the morning and declines throughout the day. Always draw at the same time for consistent comparisons.
Training: No intense exercise for 24-48 hours before bloodwork. Heavy training elevates CK, AST, inflammation markers, and can affect hormone levels.
Supplements: Take your normal supplements. You want to see what your bloodwork looks like ON your protocol, not off it. Exception: biotin supplements can interfere with some immunoassays — discontinue biotin 48 hours before if your lab panel includes thyroid or troponin markers.
Alcohol: None for 48-72 hours before bloodwork. Alcohol acutely affects liver enzymes, triglycerides, glucose, and hormone levels.
Where to Get Bloodwork
You don’t need a doctor’s order for comprehensive bloodwork. Direct-to-consumer lab services allow you to order your own panels:
Order through services like Marek Health, DiscountedLabs, or Walk-In Lab. They partner with Quest and LabCorp for professional-grade analysis. Cost for a comprehensive panel: $200-400, far less than through insurance with a doctor’s visit.
The DUTCH test (Dried Urine Test for Comprehensive Hormones) is the gold standard for detailed hormone metabolite analysis — it shows HOW your body is metabolizing hormones, not just total levels. Add this annually.
Interesting Perspectives
While the core biomarkers are non-negotiable, the frontier of bloodwork analysis is moving beyond static numbers. The most advanced practitioners are looking at dynamic responses and personalized baselines. For instance, a fasting glucose of 85 mg/dL might be “optimal” on paper, but if it spikes to 160 mg/dL after a standard meal and stays elevated for hours, you have a major metabolic problem that a single fasting snapshot misses completely. This is a direct application of the Tony Huge Laws of Biochemistry Physics — the law of dynamic equilibrium, which states that a system’s resilience is defined by its ability to return to baseline after perturbation, not just the baseline itself.
Another emerging perspective is the concept of the “Bio-Age” vs. “Chrono-Age” blood panel. Researchers are identifying combinations of biomarkers—like albumin, creatinine, glucose, and c-reactive protein—that can be algorithmically combined to calculate a biological age that often differs dramatically from chronological age. For the Enhanced Man, the goal isn’t just to have each marker in an optimal range, but to have the collective profile of a man 10-20 years younger. This shifts the focus from micromanaging individual numbers to orchestrating a symphony of biomarkers that collectively signal systemic youth and resilience.
Finally, there’s a contrarian take on frequency. The standard advice is every 3-4 months. However, for someone aggressively modulating their system with peptides or hormones, there’s an argument for ultra-frequent, minimalist tracking of 1-2 key biomarkers. For example, during a new SARM cycle, you might track ALT/AST and hematocrit with a cheap, finger-prick test every 2 weeks instead of waiting 3 months for a full panel to discover a problem that’s been brewing for 10 weeks. This “continuous bio-monitoring” approach treats bloodwork less like an annual inspection and more like a real-time engine diagnostic.
The Bottom Line
Bloodwork is not optional for the Enhanced Man. It’s the dashboard for your biological vehicle. Flying blind while running optimization protocols is like driving a race car without gauges — you might feel fast, but you have no idea if the engine is about to blow.
Get comprehensive bloodwork every 3-4 months. Learn to read your own results. Don’t accept “normal” ranges designed for sick populations. Optimize for peak performance and longevity with the Enhanced Athlete Protocol.
Ready to start monitoring? See the full Enhanced Athlete Protocol Bloodwork Guide for panel recommendations and optimal ranges.
Citations & References
This guide synthesizes decades of clinical practice and data from thousands of client panels. The following resources provide foundational science for the biomarkers discussed.
- Bhasin, S., et al. (2010). Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. (Establishes modern testosterone reference ranges and treatment thresholds).
- Otvos, J.D., et al. (2011). Clinical Implications of Discordance Between Low-Density Lipoprotein Cholesterol and Particle Number. Journal of Clinical Lipidology. (Key paper on the superiority of LDL-P over LDL-C).
- Ridker, P.M. (2003). Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention. Circulation. (Definitive work on hs-CRP as a primary inflammation and cardiac risk marker).
- Matthews, D.R., et al. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. (Original paper defining the HOMA-IR calculation).
- Holick, M.F. (2007). Vitamin D Deficiency. New England Journal of Medicine. (Seminal review establishing the high prevalence of deficiency and arguing for higher optimal targets).
- Harris, W.S., & Von Schacky, C. (2004). The Omega-3 Index: a new risk factor for death from coronary heart disease? Preventive Medicine. (Introduces the Omega-3 Index as a risk factor and target).
- Levey, A.S., et al. (2009). A New Equation to Estimate Glomerular Filtration Rate. Annals of Internal Medicine. (Foundation for modern eGFR calculations, with caveats for muscular individuals).
- Krauss, R.M. (2010). Lipoprotein subfractions and cardiovascular disease risk. Current Opinion in Lipidology. (Discusses ApoB and advanced lipidology for risk assessment).